>> Reuters
Published: 2021-01-19 18:19:29 BdST
Russia began mass trials of EpiVacCorona, which is being developed by Siberia's Vector Institute, in November.
Moscow has said its other approved COVID-19 vaccine, Sputnik V, is 92% effective at protecting people from COVID-19 according to interim results.